INTRODUCTION: The utility of blood-based Alzheimer's disease (AD) biomarkers in predicting clinical trajectories remains uncertain. METHODS: We assessed the diagnostic and prognostic performance of p-tau181, p-tau217, GFAP, and NfL in a large memory-clinic cohort (n=3,645) with comprehensive baseline clinical evaluatio...
Xue-Mei Zeng, Nicholas Heaton, Rebecca A. Deek et al.· medRxiv· 0 citations
Scalable and accessible biomarkers of neurofibrillary tangle pathology are needed for Alzheimer's disease prognosis, diagnosis and monitoring. Here, we show that a blood-based immunoassay for an endogenously-cleaved eMTBR-tau fragment of tau protein is strongly associated with autopsy-diagnosed Alzheimer neuropathologi...
R. Shi, X. Zeng, M. Farinas et al.· medRxiv· 0 citations
Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer's disease. However, the molecular basis underlying their spatial heterogeneity and biochemical complexity remain unclear. To address this, we performed mass spectrometry-based proteomic profiling of two neocortical regions with different susceptibilities to NFT...
Xue-Mei Zeng, E. Abrahamson, W. G. Balogun et al.· medRxiv· 0 citations
TDP-43 proteinopathies encompass frontotemporal lobar degeneration with TDP-43 pathology (FTLD TDP), amyotrophic lateral sclerosis (ALS TDP), and limbic predominant age related TDP-43 encephalopathy neuropathological change (LATE NC), all of which exhibit subtype-specific aggregate architectures that may constrain epit...
Xiao-Jing Zheng, Ning Zhang, Li-Xia Wang et al.· Journal of Neuropathology an...· 0 citations
These findings support further evaluation of age-contextualized plasma p-tau217 interpretation for prognosis and trial enrichment and support further evaluation of age-contextualized plasma p-tau217 interpretation for prognosis and trial enrichment.
R. Shi, L. Choity, S. Brodman et al.· medRxiv· 0 citations
A scalable, interpretable solution for vessel-level CAA analysis is provided, supporting robust geometric and spatial characterization of cerebrovascular pathology and enabling future integration with clinical and genetic studies.
H. Tahmasebidehkordi, A. Bahramy, Dana R. Julian et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.